Literature DB >> 3978101

Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasizing lymphoma (Eb) and its metastasizing variant (ESb).

D Barz, M Goppelt, M Szamel, V Schirrmacher, K Resch.   

Abstract

Plasma membrane fragments from two variants of a murine lymphoma, Eb and ESb, with different metastatic capacity were investigated. Plasma membranes were isolated from tumor cells recovered from the peritoneal cavity. They differed in their lipid composition, indicating a more fluid state of the plasma membranes derived from the highly metastatic tumor line ESb. Extracellular membrane vesicles could be isolated from the ascites of the tumor-bearing mice. The shedding capacity of ESb cells was much higher than that of Eb cells. The extracellular membranes by chemical analysis and the measurement of marker enzymes proved to be derived from the plasma membranes. However, they differed from the plasma membranes from which they were derived in several aspects: the lipid to protein ratio was diminished; the activities of some plasma membrane-associated enzymes were lower while others were identical in plasma membranes and extracellular membranes; the content of saturated fatty acids in phospholipids was enhanced in extracellular membranes. These effects were more pronounced in the highly metastasizing tumor line ESb. It is thus concluded that shedding of extracellular membranes is not a random process. The biochemical differences found in the plasma membranes and the extracellular membranes of the two tumor lines are discussed with respect to the different metastatic capacity of the tumors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978101     DOI: 10.1016/0005-2736(85)90421-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?

Authors:  Tomasz Kolenda; Kacper Guglas; Dawid Baranowski; Joanna Sobocińska; Magda Kopczyńska; Anna Teresiak; Renata Bliźniak; Katarzyna Lamperska
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-11

Review 2.  Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy.

Authors:  Bashdar Mahmud Hussen; Goran Sedeeq Hama Faraj; Mohammad Fatih Rasul; Hazha Jamal Hidayat; Abbas Salihi; Aria Baniahmad; Mohammad Taheri; Soudeh Ghafouri-Frad
Journal:  Cancer Cell Int       Date:  2022-10-18       Impact factor: 6.429

3.  Heat sensitivity and membrane properties of metastasizing and non-metastasizing rat mammary tumors.

Authors:  M B Yatvin; J W Vorpahl; S K Ghosh; U Kim; C E Elson
Journal:  Radiat Environ Biophys       Date:  1987       Impact factor: 1.925

4.  Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens.

Authors:  V Dolo; E Adobati; S Canevari; M A Picone; M L Vittorelli
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

5.  Determination of cell-free interleukin 2 receptor level in the serum of normal animals and of animals bearing IL-2 receptor positive tumours with high or low metastatic capacity.

Authors:  V Schirrmacher; O Josimovic-Alasevic; H Osawa; T Diamantstein
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

Review 6.  Tumour Derived Extracellular Vesicles: Challenging Target to Blunt Tumour Immune Evasion.

Authors:  Tatiana Lopatina; Alessandro Sarcinella; Maria Felice Brizzi
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575

7.  Expression and enhanced secretion of proteochondroitin sulphate in a metastatic variant of a mouse lymphoma cell line.

Authors:  R Schwartz-Albiez; I Steffen; A Lison; N Güttler; V Schirrmacher; R Keller
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

8.  Synovial Sarcoma Microvesicles Harbor the SYT-SSX Fusion Gene Transcript: Comparison of Different Methods of Detection and Implications in Biomarker Research.

Authors:  A Fricke; P V Ullrich; A F V Cimniak; M Follo; S Nestel; B Heimrich; I Nazarenko; G B Stark; H Bannasch; D Braig; S U Eisenhardt
Journal:  Stem Cells Int       Date:  2016-03-16       Impact factor: 5.443

Review 9.  Exosome-Based Vaccines: History, Current State, and Clinical Trials.

Authors:  Patrick Santos; Fausto Almeida
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.